ceftazidime, avibactam

CHEBI:CHEBI_756032

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1603845
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
labeler_name
Allergan, Inc.
manufacturer_name
Allergan, Inc.
listing_expiration_date
20251231
pharm_class
beta Lactamase Inhibitors [MoA]
route
INTRAVENOUS
active_ingredient_strength
.5 g/1
dosage_form
POWDER, FOR SOLUTION
marketing_start_date
20141226
package_marketing_start_date
20141226
active_ingredient_name
AVIBACTAM SODIUM
unii
9V824P8TAI
generic_name
ceftazidime, avibactam
brand_name
AVYCAZ
brand_name_base
AVYCAZ
product_ndc
0456-2700
application_number
NDA206494
spl_id
10091ebb-2574-4306-a4ac-6380188066ec
package_ndc
0456-2700-10
package_description
10 VIAL, SINGLE-DOSE in 1 CARTON (0456-2700-10) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0456-2700-01)
spl_set_id
d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class